Daratumumab 400mg/20ml solution for infusion vials
- SNOMED code
32887611000001106- Active compound
- Daratumumab
- Preferred name basis
- rINN - Recommended International Non-proprietary
- Prescribable
- ✅ Yes
- Dose form
- Discrete
- Dose size and units
- 20 ml, vial
- Ingredients
- Daratumumab
— 20 mg
/ 1 ml
based on ingredient substance
- Form & Route
- solutioninfusion.intravenous
Solution for infusion, Intravenous - Controlled drug
- No Controlled Drug Status
Products
Darzalex 400mg/20ml concentrate for solution for infusion vials (Janssen-Cilag Ltd)
in short Darzalex 400mg/20ml concentrate for inf vials
Darzalex 400mg/20ml concentrate for solution for infusion vials
- SNOMED code
32887711000001102- Supplier
- Janssen-Cilag Ltd
- Licensed as
- Medicines - MHRA/EMA
- Availability restrictions
- None
- Licensed route
- Intravenous
| Pack name & code | Status | GTIN, EAN barcodes | Price | Prescribing | Reimbursement | Pack |
|---|---|---|---|---|---|---|
Darzalex 400mg/20ml concentrate for solution for infusion vials (Janssen-Cilag Ltd) 1 vial32887911000001100 ref. pack | 💯 Available Legal category: POM | 5012674902905End: 05012674902905End: 05012674903896 | NHS Indicative Price £1,440 | • Hospital |
| — |
Reference packs
Daratumumab 400mg/20ml solution for infusion vials 1 vial
- SNOMED code
32887811000001105- Quantity and unit
- 1 vial
- Packs